Invesco
AGN

Invesco’s Allergan plc AGN Stock Holding History

Invesco’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-641,327
Closed -$114M – 3744
2020
Q1 		$114M Sell
641,327
-822,478
-56% -$155M 0.05% 463
2019
Q4 		$280M Sell
1,463,805
-417,969
-22% -$75.4M 0.09% 287
2019
Q3 		$317M Sell
1,881,774
-1,348,150
-42% -$220M 0.08% 287
2019
Q2 		$541M Sell
3,229,924
-716,403
-18% -$99.2M 0.14% 156
2019
Q1 		$578M Sell
3,946,327
-461,960
-10% -$67M 0.19% 112
2018
Q4 		$589M Buy
4,408,287
+431,174
+11% +$70.7M 0.23% 92
2018
Q3 		$758M Buy
3,977,113
+445,516
+13% +$81.8M 0.24% 84
2018
Q2 		$589M Buy
3,531,597
+232,080
+7% +$37.3M 0.19% 108
2018
Q1 		$555M Buy
3,299,517
+1,189,535
+56% +$200M 0.21% 110
2017
Q4 		$345M Sell
2,109,982
-654,936
-24% -$118M 0.12% 198
2017
Q3 		$567M Buy
2,764,918
+564,534
+26% +$131M 0.21% 108
2017
Q2 		$535M Buy
2,200,384
+37,389
+2% +$8.79M 0.17% 133
2017
Q1 		$517M Sell
2,162,995
-175,268
-7% -$40.8M 0.17% 128
2016
Q4 		$491M Sell
2,338,263
-128,379
-5% -$26.6M 0.17% 131
2016
Q3 		$568M Buy
2,466,642
+318,954
+15% +$77.9M 0.2% 106
2016
Q2 		$496M Buy
2,147,688
+340,998
+19% +$78.6M 0.18% 122
2016
Q1 		$484M Sell
1,806,690
-583,048
-24% -$167M 0.2% 112
2015
Q4 		$747M Sell
2,389,738
-808,650
-25% -$241M 0.3% 61
2015
Q3 		$869M Sell
3,198,388
-418,036
-12% -$128M 0.37% 42
2015
Q2 		$1.1B Buy
3,616,424
+577,918
+19% +$172M 0.43% 30
2015
Q1 		$904M Buy
3,038,506
+1,064,209
+54% +$303M 0.35% 46
2014
Q4 		$508M Buy
1,974,297
+309,524
+19% +$77.4M 0.2% 115
2014
Q3 		$402M Sell
1,664,773
-47,475
-3% -$10.6M 0.16% 142
2014
Q2 		$382M Buy
1,712,248
+144,290
+9% +$29.9M 0.15% 158
2014
Q1 		$323M Buy
1,567,958
+391,283
+33% +$77.5M 0.13% 179
2013
Q4 		$198M Buy
1,176,675
+532,463
+83% +$83.2M 0.08% 304
2013
Q3 		$92.8M Buy
644,212
+410,097
+175% +$54.6M 0.04% 506
2013
Q2 		$29.6M Buy
+234,115
New +$26.5M 0.01% 966

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Invesco's AGN Position: Q2 2020 in Review

Invesco sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 641,327 shares — an estimated $114M sold.

Invesco first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.1B in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Invesco reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Invesco sold 641,327 Allergan plc shares in Q2 2020, an estimated $114M.
  • Invesco first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Invesco's Allergan plc position peaked at $1.1B in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Invesco's 13F filing for Q2 2020, filed 14 Aug 2020.